[HTML][HTML] The immune response to SARS-CoV-2 in people with HIV
MA Höft, WA Burgers, C Riou - Cellular & Molecular Immunology, 2024 - nature.com
This review examines the intersection of the HIV and SARS-CoV-2 pandemics. People with
HIV (PWH) are a heterogeneous group that differ in their degree of immune suppression …
HIV (PWH) are a heterogeneous group that differ in their degree of immune suppression …
[HTML][HTML] Asplenia and spleen hypofunction
Asplenia (the congenital or acquired absence of the spleen) and hyposplenism (defective
spleen function) are common causes of morbidity and mortality. The spleen is a secondary …
spleen function) are common causes of morbidity and mortality. The spleen is a secondary …
[HTML][HTML] Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 in HIV infection: a single-arm substudy of a phase 2/3 clinical …
Background Data on vaccine immunogenicity against SARS-CoV-2 are needed for the 40
million people globally living with HIV who might have less functional immunity and more …
million people globally living with HIV who might have less functional immunity and more …
[HTML][HTML] Humoral immune responses to COVID-19 vaccination in people living with HIV receiving suppressive antiretroviral therapy
ZL Brumme, F Mwimanzi, HR Lapointe, PK Cheung… - npj Vaccines, 2022 - nature.com
Humoral responses to COVID-19 vaccines in people living with HIV (PLWH) remain
incompletely characterized. We measured circulating antibodies against the SARS-CoV-2 …
incompletely characterized. We measured circulating antibodies against the SARS-CoV-2 …
Impaired antibody response to COVID-19 vaccination in advanced HIV infection
N Hassold, S Brichler, E Ouedraogo, D Leclerc… - Aids, 2022 - journals.lww.com
Objectives: Coronavirus disease 2019 (COVID-19) vaccination is reportedly efficient in
people with HIV (PWH) but vaccine trials included participants with normal CD4+ T-cell …
people with HIV (PWH) but vaccine trials included participants with normal CD4+ T-cell …
Safety and immunogenicity of CoronaVac in people living with HIV: a prospective cohort study
LC Netto, KY Ibrahim, CM Picone, APPS Alves… - The Lancet …, 2022 - thelancet.com
Background People living with HIV might have a poor or delayed response to vaccines,
mainly when CD4 cell counts are low, and data concerning COVID-19 vaccines in this …
mainly when CD4 cell counts are low, and data concerning COVID-19 vaccines in this …
Africa: tackle HIV and COVID-19 together
Africa: tackle HIV and COVID-19 together Skip to main content Thank you for visiting nature.com.
You are using a browser version with limited support for CSS. To obtain the best experience …
You are using a browser version with limited support for CSS. To obtain the best experience …
[HTML][HTML] Anti-spike antibodies and neutralising antibody activity in people living with HIV vaccinated with COVID-19 mRNA-1273 vaccine: a prospective single-centre …
A Lombardi, GM Butta, L Donnici, G Bozzi… - The Lancet Regional …, 2022 - thelancet.com
Background Vaccines against COVID-19 are a powerful tool to control the current SARS-
CoV-2 pandemic. A thorough description of their immunogenicity among people living with …
CoV-2 pandemic. A thorough description of their immunogenicity among people living with …
Limited humoral and specific T-cell responses after SARS-CoV-2 vaccination in PWH with poor immune reconstitution
S Benet, O Blanch-Lombarte… - The Journal of …, 2022 - academic.oup.com
Background We analyzed humoral and cellular immune responses induced by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) messenger RNA (mRNA) vaccines in …
respiratory syndrome coronavirus 2 (SARS-CoV-2) messenger RNA (mRNA) vaccines in …
[HTML][HTML] Severe immunosuppression is related to poorer immunogenicity to SARS-CoV-2 vaccines among people living with HIV
A Corma-Gómez, M Fernández-Fuertes… - Clinical Microbiology …, 2022 - Elsevier
Objectives The aim of this study was to assess the immunogenicity of SARS-CoV-2 available
vaccines among people living with HIV (PLWH) after a complete vaccination scheme, and …
vaccines among people living with HIV (PLWH) after a complete vaccination scheme, and …